Skin Bleaching and Dermatologic Health of African and Afro-Caribbean Populations in the US: New Directions for Methodologically Rigorous, Multidisciplinary, and Culturally Sensitive Research
Tóm tắt
Skin-bleaching practices, such as using skin creams and soaps to achieve a lighter skin tone, are common throughout the world and are triggered by cosmetic reasons that oftentimes have deep historical, economic, sociocultural, and psychosocial roots. Exposure to chemicals in the bleaching products, notably, mercury (Hg), hydroquinone, and steroids, has been associated with a variety of adverse health effects, such as Hg poisoning and exogenous ochronosis. In New York City (NYC), skin care product use has been identified as an important route of Hg exposure, especially among Caribbean-born blacks and Dominicans. However, surprisingly sparse information is available on the epidemiology of the health impacts of skin-bleaching practices among these populations. We highlight the dearth of large-scale, comprehensive, community-based, clinical, and translational research in this area, especially the limited skin-bleaching-related research among non-White populations in the US. We offer five new research directions, including investigating the known and under-studied health consequences among populations for which the skin bleach practice is newly emerging at an alarming rate using innovative laboratory and statistical methods. We call for conducting methodologically rigorous, multidisciplinary, and culturally sensitive research in order to provide insights into the root and the epidemiological status of the practice and provide evidence of exposure-outcome associations, with an ultimate goal of developing potential intervention strategies to reduce the health burdens of skin-bleaching practice.
Tài liệu tham khảo
Dadzie OE, Petit A. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents. J Eur Acad Dermatol Venereol JEADV. 2009;23(7):741–50.
Charles CAD. Skin bleachers’ representations of skin color in Jamaica. J Black Stud. 2009;40(2):153–70.
Charles CAD. Skin bleaching, self-hate, and black identity in Jamaica. J Black Stud. 2003;33(6):711–28.
Ladizinski B, Mistry N, Kundu RV. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin. 2011;29(1):111–23.
Hope DP. From browning to cake soap: popular debates on skin bleaching in the Jamaican Dancehall. J Pan African Stud. 2011;4(4):165–94.
Mahe A. The practice of skin-bleaching for a cosmetic purpose in immigrant communities. J Travel Med. 2014;21(4):282–7.
Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol. 2003;148(3):493–500.
James C, Seixas AA, Harrison A, Jean-Louis G, Butler M, Zizi F, Samuels A. Childhood physical and sexual abuse in Caribbean young adults and its association with depression, post-traumatic stress, and skin bleaching. J Depress Anxiety. 2016;5(1):214.
Mahe A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101(2):183–7.
Al-Saleh I. Potential health consequences of applying mercury-containing skin-lightening creams during pregnancy and lactation periods. Int J Hyg Environ Health. 2016;219(4–5):468–74.
Petit A, Cohen-Ludmann C, Clevenbergh P, Bergmann JF, Dubertret L. Skin lightening and its complications among African people living in Paris. J Am Acad Dermatol. 2006;55(5):873–8.
Barr RD, Rees PH, Cordy PE, Kungu A, Woodger BA, Cameron HM. Nephrotic syndrome in adult Africans in Nairobi. Br Med J. 1972;2(5806):131–4.
Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, Onyekonwu C, Essen N. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.
Chan TY. Inorganic mercury poisoning associated with skin-lightening cosmetic products. Clin Toxicol. 2011;49(10):886–91.
Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol. 2001;2(4):213–7.
Simmons BJ, Griffith RD, Bray FN, Falto-Aizpurua LA, Nouri K. Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments. Am J Clin Dermatol. 2015;16(3):205–12.
Cristaudo A, D’llio S, Gallinella B, Mosca A, Majorani C, Violante N, Senofonte O, Morrone A, Petrucci F. Use of potentially harmful skin-lightening products among immigrant women in Rome, Italy: a pilot study. Dermatology 2013, 226(3):200–6.
Maneli MH, Wiesner L, Tinguely C, Davids LM, Spengane Z, Smith P, van Wyk JC, Jardine A, Khumalo NP. Combinations of potent topical steroids, mercury and hydroquinone are common in internationally manufactured skin-lightening products: a spectroscopic study. Clin Exp Dermatol. 2016;41(2):196–201.
EU. EU regulation 1223/2009, of the European parliament and of the Council of 30 November 2009, official J L 342/59 (22 December 2009). http://refhub.elsevier.com/S0731-7085(13)00552-9/sbref0015 2009. Accessed 14 May 2016.
FDA. Ruelmaking history for OTC skin bleaching drug products. http://www.fdagov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm072117htm#Original 1990. Accessed 3 May 2016.
Thacker P. Another African nation bans popular skin-whitening creams. http://nytlive.nytimes.com/womenintheworld/2015/05/12/another-african-nation-bans-popular-skin-whitening-creams/ 2015. Accessed 5 May 2016.
FDA. Guide to inspections of cosmetic product manufacturers: mercury compounds (codified at 21 CFR §700.13). Federal Register February. 21CFR70013. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearchcfm?fr=70013&SearchTerm=mercury 1995. Accessed 14 May 2016.
WHO. Mercury in skin lightening products. http://www.whoint/ipcs/assessment/public_health/mercury_flyerpdf 2011. Accessed 3 May 2016.
Mistry N, Shapero J, Kundu RV, Shapero H. Toxic effects of skin-lightening products in Canadian immigrants. J Cutan Med Surg. 2011;15(5):254–8.
Hamann CR, Boonchai W, Wen L, Sakanashi EN, Chu CY, Hamann K, Hamann CP, Sinniah K, Hamann D. Spectrometric analysis of mercury content in 549 skin-lightening products: is mercury toxicity a hidden global health hazard? J Am Acad Dermatol 2014, 70(2):281–7 (e283).
McKelvey W, Jeffery N, Clark N, Kass D, Parsons PJ. Population-based inorganic mercury biomonitoring and the identification of skin care products as a source of exposure in New York City. Environ Health Perspect. 2011;119(2):203–9.
CDC. Mercury poisoning associated with beauty cream—Texas, New Mexico, and California, 1995–1996. Centers for Disease Control and Prevention. MMWR 1996, 45(19):400–3.
CDC. Mercury exposure among household users and nonusers of skin-lightening creams produced in Mexico—California and Virginia, 2010. Centers for Disease Control and Prevention. MMWR 2012, 61(2):33–6.
Weldon MM, Smolinski MS, Maroufi A, Hasty BW, Gilliss DL, Boulanger LL, Balluz LS, Dutton RJ. Mercury poisoning associated with a Mexican beauty cream. Western J Med. 2000;173(1):15–8.
Kooyers TJ, Westerhof W. Toxicology and health risks of hydroquinone in skin lightening formulations. J Eur Acad Dermatol. 2006;20(7):777–80.
O’Donoghue JL. Hydroquinone and its analogues in dermatology—a risk-benefit viewpoint. J Cosmet Dermatol. 2006;5(3):196–203.
Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 17–24 February 1998. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 1999, 71(Pt 1):1–315.
Desmedt B, Van Hoeck E, Rogiers V, Courselle P, De Beer JO, De Paepe K, Deconinck E. Characterization of suspected illegal skin whitening cosmetics. J Pharmaceut Biomed. 2014;90:85–91.
Enguita FJ, Leitao AL. Hydroquinone: environmental pollution, toxicity, and microbial answers. Biomed Res Int. 2013;2013:542168.
Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84(3):539–49.
Brenner M, Hearing VJ. Modifying skin pigmentation—approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech. 2008;5(2):e189–99.
Desmedt B, Rogiers V, Courselle P, De Beer JO, De Paepe K, Deconinck E. Development and validation of a fast chromatographic method for screening and quantification of legal and illegal skin whitening agents. J Pharm Biomed Anal. 2013;83:82–8.
Wang YH, Avonto C, Avula B, Wang M, Rua D, Khan IA. Quantitative determination of alpha-arbutin, beta-arbutin, kojic acid, nicotinamide, hydroquinone, resorcinol, 4-methoxyphenol, 4-ethoxyphenol, and ascorbic acid from skin whitening products by HPLC-UV. J AOAC Int. 2015;98(1):5–12.